The Prostate Cancer Clinical Trials Consortium (PCCTC)

BREAKING: We need you to know about a critical development that directly impacts cancer research funding. Speaker of the House, Mike Johnson, has scheduled a vote for this Tuesday, March 11th, on a continuing resolution extension bill that includes a 57% cut to the Congressionally Directed Medical Research Programs, a devastating blow to federal research funding for prostate cancer and many other vitally important public health issues. This reduction would significantly undermine progress in developing new treatments and improving patient outcomes. Please contact your elected officials: https://lnkd.in/e4DzN3c4

TheranosticTrials.Org is proud to recognize Michael J. Morris as one of our Distinguished Investigators. Dr. Morris is a prostate cancer specialist, clinical investigator, and the Section Head of Prostate Cancer of the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center. He earned his medical degree from the Mount Sinai School of Medicine in New York and performed his internship and residency in Internal Medicine at Columbia Presbyterian Medical Center. He then completed his medical oncology fellowship at Memorial Sloan Kettering Cancer Center, where is also was Chief Fellow. Over the past several decades, Dr. Morris has had a particular research focus on targeted therapy for prostate cancer, especially those that bridge the fields of Medical Oncology and Nuclear Medicine. In the field of therapeutics, he has focused on tumor and bone-directed radiopharmaceuticals for prostate cancer, both as single agents and as combinatorial regimens. He was a member of the leadership team that developed Lu-177 PSMA-617, which is now FDA approved for men with advanced prostate cancer. He now leads research programs to develop new prostate-specific targets bearing new payloads using novel targeting agents. He has a research interest in developing novel imaging technologies for metastatic prostate cancer and in credentialing imaging biomarkers. He has been a co-developer of the Prostate Cancer Working Group 2 and 3 Consensus Criteria, and prostate-specific imaging technologies such as PSMA-directed PET imaging. In addition, he is the Medical Director of the Prostate Cancer Clinical Trials Consortium. He has long had an interest in novel methods of implementing prostate cancer clinical trials, and utilizing digital methods to reduce barriers to expertise, clinical care, and investigational studies. To learn more visit theranostictrials.org #theranostictrials #investigators #theranostics #clinicaltrials #xcancer

CALL TO ACTION. On Tuesday, Congress will vote on a continuing resolution that includes a 57% cut to the Congressionally Directed Medical Research Program and its long-standing Prostate Cancer Research Program, one of the most effective programs in the world designed to produce treatments and, one day, a cure for prostate cancer. Contact your elected officials today and urge them to vote NO on this harmful bill: https://lnkd.in/e4DzN3c4

PCCTC patient and research advocate Jan Manarite of YourProstateCancerHelp dispels the myths of the use of placebos in contemporary prostate cancer clinical studies: https://lnkd.in/erZ7vEti

Urology Practice publishes peer-reviewed study authored by Dr. Keith Crawford and Thomas Farrington of The Prostate Health Education Network (PHEN) and PCCTC CEO Jake Vinson identifying factors affecting the accrual of Black males into prostate cancer clinical trials in the United States. Full article can be found here: https://lnkd.in/eqEbHF9v

The PCCTC is now on Bluesky! Follow us at https://lnkd.in/e6qs2e2X

The Prostate Cancer Clinical Trials Consortium (PCCTC) is pleased to announce its Summer 2025 internships. Opportunities are available in Data Management, Data Science, and Clinical Operations. To learn more visit individual links below: Data Management: https://lnkd.in/ermvu-Py Data Science: https://lnkd.in/e6vDSXdy Clinical Operations: https://lnkd.in/e6Q6RuyG

Now Hiring! The PCCTC is seeking an experienced Clinical Data Standards Manager to support our clinical research team. For full details please visit: https://lnkd.in/gR7p2_29

The PCCTC Highlighted in CDMRP Report on Impactful Prostate Cancer Research to Improve the Lives of Those Affected: https://lnkd.in/epSE3p_h